Issue 633 • May 2022 A strategic approach to build firm capacity Class actions and collective claims making an impact in the UK From prediction to action – how AI is changing treasury Compliance, anti-bribery and corruption in the pharmaceutical industry Complex distribution networks, varied pricing and powerful customers make the pharmaceutical industry particularly vulnerable to fraud and corruption. But what are the specific threats, and how can organisations best address them? 05/24/2022 19:27:45
